Showing results (131-140 of 4,234) with videos related to
Sort By:
Pageof 424
Journal for Immunotherapy of Cancer|September 28, 2022
Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitisAmelie Franken, Pierre Van Mol, Sam Vanmassenhove, et al.Journal for Immunotherapy of Cancer|September 30, 2022
Ironing out exercise on immuno-oncological outcomesJanjira Soh, Zi Xiang Lim, Elaine Hsuen Lim, et al.Journal for Immunotherapy of Cancer|October 12, 2022
Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumorsSven Borchmann, Carolin Selenz, Mia Lohmann, et al.Journal for Immunotherapy of Cancer|March 12, 2021
Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemicRenee N Donahue, Jennifer L Marté, Meghali Goswami, et al.Journal for Immunotherapy of Cancer|January 7, 2022
Role of Fcγ receptors in HER2-targeted breast cancer therapyAntonino Musolino, William J Gradishar, Hope S Rugo, et al.Journal for Immunotherapy of Cancer|January 7, 2022
Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trialLukas Rob, David Cibula, Pawel Knapp, et al.Journal for Immunotherapy of Cancer|January 8, 2022
Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinomaBoyuan Liu, Zewei Zhou, Yu Jin, et al.Journal for Immunotherapy of Cancer|January 8, 2022
Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)Marc Wehrli, Kathleen Gallagher, Yi-Bin Chen, et al.Journal for Immunotherapy of Cancer|November 19, 2015
Quantitative real-time PCR assisted cell counting (qPACC) for epigenetic - based immune cell quantification in blood and tissueThomas Oliver Kleen, Jianda YuanJournal for Immunotherapy of Cancer|November 19, 2015
A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trialAmabel Cl Tan, Anne Goubier, Holbrook E KohrtPageof 424